Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty

NCT04743063 · clinicaltrials.gov ↗

UNKNOWN

Status

40000

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure, Systolic
Frailty

Interventions

DRUG: sacubitril/valsartan
DRUG: Angiotensin II Receptor Blockers

Sponsor

Brigham and Women's Hospital